Alberta Investment Management Corp (AIMCo)’s Myriad Genetics MYGN Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,515	Closed	-$366K	–	1328
2022 Q1	$366K	Buy	+14,515	New	+$371K	﹤0.01%	1161
2017 Q3	–	Sell	-24,800	Closed	-$641K	–	780
2017 Q2	$641K	Buy	+24,800	New	+$526K	0.01%	614
2014 Q1	–	Sell	-101,839	Closed	-$2.14M	–	486
2013 Q4	$2.14M	Sell	101,839 -192,611	-65%	-$4.87M	0.03%	399
2013 Q3	$6.92M	Buy	+294,450	New	+$8.37M	0.09%	287

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s MYGN Position: Q2 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Myriad Genetics (MYGN) in Q2 2022, closing a stake of 14,515 shares — an estimated $366K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in MYGN in Q3 2013 and held it in 4 quarters. The position peaked at $6.92M in Q3 2013. 198 funds tracked by Wall St. Rank hold MYGN as of Q2 2022.

Alberta Investment Management Corp (AIMCo) reported no remaining Myriad Genetics position as of Q2 2022 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 14,515 Myriad Genetics shares in Q2 2022, an estimated $366K.
Alberta Investment Management Corp (AIMCo) first reported a position in Myriad Genetics in Q3 2013 and held it in 4 quarters.
Alberta Investment Management Corp (AIMCo)'s Myriad Genetics position peaked at $6.92M in Q3 2013.
198 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2022, filed 15 Aug 2022.